| Citation: |
TIAN Yuan, MA Liuyi, LIU Qianqian, HAN Dongdong, ZHOU Xiaoyan, GAO Min. Effect of enteral nutrition formula containing slow-release starch on blood glucose variability and prognosis in patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2025, 29(7): 64-70. DOI: 10.7619/jcmp.20246108
|
To explore the impact of enteral nutrition formula containing slow-release starch on blood glucose variability and prognosis in patients with severe acute pancreatitis (SAP).
A total of 204 SAP patients were enrolled and randomly divided into control group and observation group using a random number table method, with 102 patients in each group. The control group received early enteral nutrition support with a standard enteral nutrition formula, while the observation group received early enteral nutrition support with an enteral nutrition formula containing slow-release starch. Blood glucose variability indicators[largest amplitude of glycemic excursions (LAGE), standard deviation of blood glucose (SDBG), blood glucose coefficient of variation (BGCV), mean blood glucose (MBG), mean amplitude of glycemic excursions (MAGE), and time in range (TIR)]were compared between the two groups after treatment, along with clinical indicators during hospitalization, inflammatory markers[procalcitonin, C-reactive protein, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)], and nutritional indicators (albumin, prealbumin) levels. Kaplan-Meier analysis was conducted to assess the prognosis of the two groups, and multivariate Cox regression analysis was performed to identify factors influencing prognosis.
After treatment, the observation group exhibited lower levels of MBG, LAGE, SDBG, BGCV, MAGE, and a higher TIR compared with the control group (P < 0.05). During hospitalization, the observation group had a shorter duration of enteral nutritiontherapy, lower insulin usage, and lower incidence rates of multiple organ failure and infectious pancreatic necrosis compared with the control group (P < 0.05). After treatment, the observation group had lower levels of procalcitonin, C-reactive protein, IL-6, and TNF-α compared with the control group (P < 0.05); however, there were no statistically significant differences in albumin and prealbumin levels between the two groups (P>0.05). Kaplan-Meier analysis showed that the cumulative mortality rate in the observation group was 12.75%, which was lower than the 17.65% in the control group (Log-rank χ2=4.361, P=0.037). Multivariate Cox regression analysis revealed that TIR after treatment (HR=0.920; 95%CI, 0.869 to 0.974) was an independent protective factor for prognosis in SAPpatients (P < 0.05), while infectious pancreatic necrosis (HR=4.269; 95%CI, 1.922 to 9.482) was an independent risk factor for prognosis in SAP patients (P < 0.05).
Enteral nutrition formula containing slow-release starch helps stabilize blood glucose variability, control inflammatory marker levels, improve nutritional status, and prognosis in SAP patients. Both TIR and infectious pancreatic necrosis are closely related to the prognosis of SAP patients.
| [1] |
张佳旭, 杨婷, 李燃. 中老年重症急性胰腺炎患者住院期间死亡预测模型的构建与验证[J]. 实用临床医药杂志, 2024, 28(17): 51-55. doi: 10.7619/jcmp.20241933
|
| [2] |
罗玮玮, 董小武, 王凝之, 等. 基于Web of Science数据库对急性胰腺炎相关研究的文献计量与可视化分析[J]. 实用临床医药杂志, 2023, 27(19): 101-106. doi: 10.7619/jcmp.20232206
|
| [3] |
陈从林, 罗和生. 血常规、生化指标对重症急性胰腺炎的预测价值探讨[J]. 胃肠病学和肝病学杂志, 2023, 32(1): 20-25.
|
| [4] |
LU Y, ZHANG Q H, LOU J J. Blood glucose-related indicators are associated with in-hospital mortality in critically ill patients with acute pancreatitis[J]. Sci Rep, 2021, 11(1): 15351. doi: 10.1038/s41598-021-94697-1
|
| [5] |
OHSHIRO Y. Blood glucose variability in patients with acute pancreatitis[J]. United European Gastroenterol J, 2022, 10(4): 438. doi: 10.1002/ueg2.12224
|
| [6] |
WANG D Y, LU J, ZHANG P, et al. Relationship between blood glucose levels and length of hospital stay in patients with acute pancreatitis: an analysis of MIMIC-Ⅲ database[J]. Clin Transl Sci, 2023, 16(2): 246-257. doi: 10.1111/cts.13445
|
| [7] |
中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 浙江实用医学, 2021, 26(6): 511-519, 535.
|
| [8] |
JIN Y Z, TAO S Y, YU G, et al. Predictive value of hyperglycemia on infection in critically ill patients with acute pancreatitis[J]. Sci Rep, 2023, 13(1): 4106. doi: 10.1038/s41598-023-30608-w
|
| [9] |
YANG X M, ZHANG R W, JIN T, et al. Stress hyperglycemia is independently associated with persistent organ failure in acute pancreatitis[J]. Dig Dis Sci, 2022, 67(5): 1879-1889. doi: 10.1007/s10620-021-06982-8
|
| [10] |
DUNGAN K M, HART P A, ANDERSEN D K, et al. Assessing the pathophysiology of hyperglycemia in the diabetes RElated to acute pancreatitis and its mechanisms study: from the type 1 diabetes in acute pancreatitis consortium[J]. Pancreas, 2022, 51(6): 575-579. doi: 10.1097/MPA.0000000000002074
|
| [11] |
NAGY A, JUHÁSZ M F, GÖRBE A, et al. Glucose levels show independent and dose-dependent association with worsening acute pancreatitis outcomes: Post-hoc analysis of a prospective, international cohort of 2250 acute pancreatitis cases[J]. Pancreatology, 2021, 21(7): 1237-1246. doi: 10.1016/j.pan.2021.06.003
|
| [12] |
BHARMAL S H, CHO J, KO J, et al. Glucose variability during the early course of acute pancreatitis predicts two-year probability of new-onset diabetes: a prospective longitudinal cohort study[J]. United European Gastroenterol J, 2022, 10(2): 179-189. doi: 10.1002/ueg2.12190
|
| [13] |
CAI Y, WANG C, DI W, et al. Correlation between blood glucose variability and the risk of death in patients with severe acute stroke[J]. Rev Neurol (Paris), 2020, 176(7/8): 582-586.
|
| [14] |
LAZZERI C, BONIZZOLI M, BATACCHI S, et al. The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress Syndrome[J]. Diabetes Res Clin Pract, 2021, 175: 108789. doi: 10.1016/j.diabres.2021.108789
|
| [15] |
WANG Y L, ZHOU X, XIANG X S, et al. Association of slowly digestible starch intake with reduction of postprandial glycemic response: an update meta-analysis[J]. Foods, 2022, 12(1): 89. doi: 10.3390/foods12010089
|
| [16] |
TANG Q Y, CHENG Y Q. Enteral nutrition: based on the combination of nutrison fibre and TPF-DM with A marine biological-based active polysaccharide preparation[J]. Comput Math Methods Med, 2022, 2022: 6213716.
|
| [17] |
程飞, 翁延宏, 陈伟. 早期肠内营养在急性胰腺炎病人中的应用分析[J]. 肠外与肠内营养, 2022, 29(3): 150-154.
|
| [18] |
孙娟, 任鸿萍. 早期肠内营养对重症急性胰腺炎患者胃肠道功能恢复情况及预后的影响[J]. 国际护理学杂志, 2022, 41(3): 476-481.
|
| [19] |
LAESSER C I, CUMMING P, REBER E, et al. Management of glucose control in noncritically ill, hospitalized patients receiving parenteral and/or enteral nutrition: a systematic review[J]. J Clin Med, 2019, 8(7): 935. doi: 10.3390/jcm8070935
|
| [20] |
RICHARDSON A, PARK W G. Acute pancreatitis and diabetes mellitus: a review[J]. Korean J Intern Med, 2021, 36(1): 15-24. doi: 10.3904/kjim.2020.505
|
| [21] |
吴光理, 朱子宜. 强化血糖控制对急性胰腺炎患者血糖波动及新发糖尿病的影响[J]. 浙江临床医学, 2017, 19(1): 113-114.
|
| 1. |
楚成华, 郭翠英, 邓文龙. 腰椎内固定术后出现反复下腰痛原因分析. 临床医药文献电子杂志. 2018(83): 20 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: